Greenwich LifeSciences, Inc. logo

GLSIGreenwich LifeSciences, Inc.

GLSI Stock Price, Valuation & Chart | Greenwich LifeSciences, Inc.

Compare

GLSI Historical price chart

GLSI Key Stats

Fair Value
Disclaimer

Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.

Market Capitalization231.03M
PE Ratio-12.02
EPS-1.31
Trading Volume102.78K
Today's High/Low16.05/14.99
Dividend Yield0.00
52 Week High/Low34.1/7.78
Shares Outstanding14.68M
GLSI Financial Statement
GLSI Analyst ratings
GLSI Analysis & performance metrics

GLSI Company profile

Greenwich LifeSciences, Inc., a clinical stage biopharmaceutical company, focuses on the development of novel cancer immunotherapies for breast cancer and other…

GLSI Management team

Management
Eric RotheCTO
Founder & Independent Director
Christine T. Fischette Ph.D.
Vice President of Business Development
Snehal S. PatelCEO
Chief Executive Officer, Chief Financial Officer & Director
Jaye L. Thompson Ph.D.
Vice President Clinical & Regulatory Affairs
Frank Joseph Daugherty M.D.CTO
Chief Medical Officer & Director
Total 5 executives

GLSI Frequently asked questions

What is Greenwich LifeSciences, Inc. (GLSI) Stock Price?

Current stock price of Greenwich LifeSciences, Inc. (GLSI) stock is $15.740. The stock price is +4.86% higher in the session. The intraday range can be seen from this page. Volume of Greenwich LifeSciences, Inc. (GLSI) stock is 102.78K.

Last updated at 02 Sept 2026, 08:00 pm.

Why is the Greenwich LifeSciences, Inc. (GLSI) stock price going up or down today?

The stock price of Greenwich LifeSciences, Inc. (GLSI) can change with earnings, company news, and overall market sentiment. Greenwich LifeSciences, Inc. operates in the Healthcare / Biotechnology market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the Greenwich LifeSciences, Inc. stock expensive at its current price?

Whether Greenwich LifeSciences, Inc. looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for GLSI on this page is -12.02. EPS on this page is -1.31. Compare those figures with peers and growth expectations before deciding if the current Greenwich LifeSciences, Inc. price is justified.

How has the stock price of Greenwich LifeSciences, Inc. (GLSI) performed historically?

Historical performance for Greenwich LifeSciences, Inc. (GLSI) is shown on the price chart on this page. Review multi-period moves alongside volume to see how GLSI reacted to past earnings and market events.

Should I buy Greenwich LifeSciences, Inc. (GLSI) stock, at this price?

Buying Greenwich LifeSciences, Inc. (GLSI) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.